<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00957606</url>
  </required_header>
  <id_info>
    <org_study_id>PCa &amp; Osteoporosis 09</org_study_id>
    <secondary_id>S-20080004</secondary_id>
    <nct_id>NCT00957606</nct_id>
  </id_info>
  <brief_title>Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer</brief_title>
  <acronym>Osteoporosis</acronym>
  <official_title>Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer: Symptoms, Risc Factors, and Prevention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Zealand University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is

        -  to determine the rate of osteoporosis among patients with advanced prostate cancer.

        -  to propose an algorithm for early detection of patients with advanced prostate cancer
           who are at risk of developing osteoporosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with advanced prostate cancer are included at the initiating of androgen deprivation
      therapy.

      The patients are followed for 2 years after inclusion with blood sampling, DXA-scan,
      questionnaire, bone scintigraphy.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2009</start_date>
  <completion_date type="Anticipated">September 2013</completion_date>
  <primary_completion_date type="Anticipated">March 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Osteoporosis, either T-score &lt; -2,5 or osteoporosis fracture</measure>
    <time_frame>2½ years</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Prostate Cancer</condition>
  <condition>Androgen Deprivation Therapy</condition>
  <condition>Osteoporosis</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>blood sampling, DXA-scan, bone scintigraphy</intervention_name>
    <description>Blood sampling 5 times DXA-scan 5 times Bone scintigraphy 3 times</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Prostate cancer

          -  Initiation of androgen deprivation therapy

          -  Oral and written informed consent

        Exclusion Criteria:

          -  They withdraw their consent

          -  Treatment for osteoporosis within the last year

          -  Other malignancy

          -  Other bone disease, bedbound, use of steroid
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mads H Poulsen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Urology, Odense University Hospital, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Steen Walter, MD, DMSci, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Urology, Odense University Hospital, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Morten MF Nielsen, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Endocrinology, Odense University Hospital, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kim Brixen, MD, PhD, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Endocrinology, Odense University Hospital, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claus Dahl, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Urology, Roskilde Hospital, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter Eskildsen, MD, DMSci</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Endocrinology, Køge Hospital, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Oke Gerke, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Southern Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bo Abrahamsen, MD, PhD, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Faculty of Health Sciences, University of Southern Denmark, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mads H Poulsen, MD</last_name>
    <email>Mads.Poulsen@ouh.regionsyddanmark.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Steen Walter, MD, DMSci, Professor</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Urology, Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mads H Poulsen, MD</last_name>
      <email>Mads.Poulsen@ouh.regionsyddanmark.dk</email>
    </contact>
    <contact_backup>
      <last_name>Steen Walter</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Department of Urology, Roskilde Hospital</name>
      <address>
        <city>Roskilde</city>
        <zip>4000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claus Dahl, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 11, 2009</study_first_submitted>
  <study_first_submitted_qc>August 11, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 12, 2009</study_first_posted>
  <last_update_submitted>April 12, 2011</last_update_submitted>
  <last_update_submitted_qc>April 12, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 13, 2011</last_update_posted>
  <responsible_party>
    <name_title>Mads Hvid Poulsen, MD</name_title>
    <organization>Department of Urology, Odense University Hospital, Denmark</organization>
  </responsible_party>
  <keyword>Prostate cancer</keyword>
  <keyword>androgen deprivation therapy</keyword>
  <keyword>osteoporosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
    <mesh_term>Osteoporosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Androgens</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

